Interestingly, breast cancer cell lines showing high level of RBBP7 expression were more sensitive to LSD1 inhibitor ORY-1001 (iadademstat), which effectively reduced the expression of stemness genes and CCND1. Here, RBBP7 is linked to breast carcinoma.